5 Stocks Setting Up to Break Out
Corcept Therapeutics
Another pharmaceutical stock that's quickly moving within range of triggering a near-term breakout trade is Corcept Therapeutics (CORT), which is engaged in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders. This stock has been hammered by the bears during the last six months, with shares off a large 46%.
If you take a look at the chart for Corcept Therapeutics, you'll notice that this stock has been uptrending strong for the last three months, with shares soaring from its low of $1.27 to its recent high of $2.20 a share. During that uptrend, shares of CORT have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed CORT within range of triggering a near-term breakout trade.
Market players should now look for long-biased trades in CORT if it manages to break out above some near-term overhead resistance at $2.20 a share with high volume. Look for a sustained move or close above $2.20 a share with volume that registers near or above its three-month average action of 622,545 shares. If that breakout hits soon, then CORT will set up to re-test or possibly take out its next major overhead resistance levels at $2.50 to $2.75 a share. Any move above $2.75 will then put $2.89 to $3.03 into range for shares of CORT.
Traders can look to buy CORT off any weakness to anticipate that breakout and simply use a stop that sits close to some key near-term support at $1.80 a share. One could also buy off strength once CORT clears $2.20 a share with volume and then simply use a stop that sits just below $2 a share.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV